Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Orchard Therapeutics Plc ADR (NQ: ORTX ) N/A UNCHANGED Last Price Updated: 4:00 PM EST, Jan 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Orchard Therapeutics Plc ADR < Previous 1 2 3 4 5 Next > Orchard Therapeutics Announces Comprehensive Presence at 19th Annual WORLDSymposium February 08, 2023 Four oral presentations and 11 posters highlight transformative potential of HSC gene therapy and newborn screening to address severe neurometabolic diseases From Orchard Therapeutics (Europe) Limited Via GlobeNewswire Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday January 27, 2023 It's time to start the final day of trading this week with a look at the biggest pre-market stock movers for Friday morning! Via InvestorPlace Orchard Therapeutics Highlights Recent Progress Across HSC Gene Therapy Portfolio and Outlines Key 2023 Milestones January 09, 2023 From Orchard Therapeutics (Europe) Limited Via GlobeNewswire Orchard Therapeutics: Q1 Earnings Insights May 12, 2022 Orchard Therapeutics (NASDAQ:ORTX) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Via Benzinga Recap: Orchard Therapeutics Q4 Earnings March 30, 2022 Orchard Therapeutics (NASDAQ:ORTX) reported its Q4 earnings results on Wednesday, March 30, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Via Benzinga Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session January 06, 2023 Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 133% to $0.3218. Swvl recently announced the commencement of a strategic review process. Via Benzinga Why Graphite Bio Shares Are Trading Lower By 50%; Here Are 20 Stocks Moving Premarket January 06, 2023 Gainers OncoCyte Corporation (NASDAQ: OCX) rose 89.2% to $0.70 in pre-market trading. Oncocyte, last month, announced an over 40% reduction of its workforce to realign the team towards key products... Via Benzinga Why ABVC BioPharma Shares Are Trading Higher By 129%? Here Are Other Stocks Moving In Thursday's Mid-Day Session January 05, 2023 Gainers Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) shares surged 179.3% to $2.4585 after the company announced that it has entered into a license agreement for the development and commercialization... Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session January 05, 2023 Via Benzinga Orchard Therapeutics Announces U.S. FDA Clearance of IND Application for OTL-203 in MPS-IH January 05, 2023 Global registrational trial expected to commence in the second half of 2023 From Orchard Therapeutics (Europe) Limited Via GlobeNewswire Orchard Therapeutics Announces Promising Early Neurocognitive Outcomes from Ongoing Proof-of-concept Study of OTL-201 in MPS-IIIA December 12, 2022 From Orchard Therapeutics (Europe) Limited Via GlobeNewswire Orchard Therapeutics Announces Swissmedic Validation of the Marketing Authorization Application for Libmeldy (atidarsagene autotemcel) December 01, 2022 From Orchard Therapeutics (Europe) Limited Via GlobeNewswire Orchard Therapeutics Reports Third Quarter 2022 Financial Results and Reviews Recent Business Highlights November 14, 2022 From Orchard Therapeutics (Europe) Limited Via GlobeNewswire Orchard Therapeutics to Present at Multiple Investor Conferences in November 2022 November 08, 2022 From Orchard Therapeutics (Europe) Limited Via GlobeNewswire Orchard Therapeutics to Webcast Conference Call of Third Quarter 2022 Financial Results November 07, 2022 From Orchard Therapeutics (Europe) Limited Via GlobeNewswire Orchard Therapeutics Announces First Neurocognitive Data from OTL-201 Study in MPS-IIIA Accepted for Oral Presentation at ASH 2022 November 03, 2022 Company to host KOL conference call and webcast on Monday, December 12 at 5:00 p.m. EST From Orchard Therapeutics (Europe) Limited Via GlobeNewswire Earnings Scheduled For November 14, 2022 November 14, 2022 Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million. Via Benzinga Why Olaplex Holdings Shares Are Trading Lower By 42%; Here Are 27 Stocks Moving Premarket October 19, 2022 Gainers SenesTech, Inc. (NASDAQ: SNES) shares rose 65.8% to $0.3847 in pre-market trading after declining over 3% on Tuesday. Via Benzinga Orchard Announces Multiple Presentations at 2022 ESGCT Annual Congress Showing the Potential of HSC Gene Therapy in Several Therapeutic Areas October 10, 2022 From Orchard Therapeutics (Europe) Limited Via GlobeNewswire 12 Health Care Stocks Moving In Monday's Pre-Market Session October 03, 2022 Gainers LogicBio Therapeutics (NASDAQ:LOGC) shares moved upwards by 641.3% to $2.02 during Monday's pre-market session. The company's market cap stands at $66.5 million. Via Benzinga Why Celyad Oncology Is Trading Higher By Over 31%; Here Are 29 Stocks Moving Premarket August 01, 2022 Gainers MAIA Biotechnology, Inc. (NASDAQ: MAIA) rose 37.9% to $8.00 in pre-market trading after jumping 30% on Friday. The company agreed to initially offer 2.00 million shares to the public at a $5.00... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session June 01, 2022 Via Benzinga The Daily Biotech Pulse: Bristol Myers, BridgeBio Ink Oncology Pact, FDA Nod For Lava Therapeutics Blood Cancer Study And More May 12, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Earnings Scheduled For May 12, 2022 May 12, 2022 Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its first quarter. Via Benzinga Orchard Therapeutics Earnings Preview May 11, 2022 Orchard Therapeutics (NASDAQ:ORTX) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that... Via Benzinga Executives Buy More Than $1.5M Of 3 Penny Stocks April 06, 2022 US crude oil futures traded higher this morning. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For April 1, 2022 April 01, 2022 Upgrades Via Benzinga Orchard Therapeutics Plans To Seek Strategic Options For Immunodeficiency Programs, Cuts Workforce March 30, 2022 Orchard Therapeutics plc (NASDAQ: ORTX) announced its Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2022 March 31, 2022 Upgrades Via Benzinga Earnings Scheduled For March 30, 2022 March 30, 2022 Companies Reporting Before The Bell • Orgenesis (NASDAQ:ORGS) is likely to report earnings for its fourth quarter. • RumbleON (NASDAQ:RMBL) is estimated to report earnings for its Fiscal Year 2021. Via Benzinga < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.